Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, April 16, 2015, 51 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $14.00 to $6,188,242.50.

Highlighted Stocks Traded by Insiders:

Illumina (ILMN) - FREE Research Report

Henry Christian O, who is Sr VP & Chief Commercial Offic at Illumina, sold 3,751 shares at $189.02 on April 16, 2015. Following this transaction, the Sr VP & Chief Commercial Offic owned 39,308 shares meaning that the stake was reduced by 8.71% with the 3,751-share transaction.

Naclerio Nicholas, who is Sr VP, Corporate Development at Illumina, sold 6,590 shares at $189.05 on April 16, 2015. Following this transaction, the Sr VP, Corporate Development owned 41,457 shares meaning that the stake was reduced by 13.72% with the 6,590-share transaction.

The shares most recently traded at $190.27, up $1.22, or 0.64% since the insider transaction. Historical insider transactions for Illumina go as follows:

  • 4-Week # shares sold: 25,489
  • 12-Week # shares sold: 108,495
  • 24-Week # shares sold: 155,417

The average volume for Illumina has been 1.1 million shares per day over the past 30 days. Illumina has a market cap of $27.4 billion and is part of the health care sector and drugs industry. Shares are up 3.19% year-to-date as of the close of trading on Thursday.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company has a P/E ratio of 80.4. Currently, there are 12 analysts who rate Illumina a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ILMN - FREE

TheStreet Quant Ratings rates Illumina as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Illumina Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Bassett Furniture Industries (BSET) - FREE Research Report

Hervey Jay R, who is Vice Pres Sec & Gen Counsel at Bassett Furniture Industries, sold 1,100 shares at $32.45 on April 16, 2015. Following this transaction, the Vice Pres Sec & Gen Counsel owned 13,301 shares meaning that the stake was reduced by 7.64% with the 1,100-share transaction.

The shares most recently traded at $30.85, down $1.60, or 5.18% since the insider transaction. Historical insider transactions for Bassett Furniture Industries go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 3,000
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 7,000
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 7,000

The average volume for Bassett Furniture Industries has been 66,400 shares per day over the past 30 days. Bassett Furniture Industries has a market cap of $340.2 million and is part of the consumer goods sector and consumer durables industry. Shares are up 62.69% year-to-date as of the close of trading on Thursday.

Bassett Furniture Industries, Incorporated manufactures, imports, and retails home furnishings in the United States. The company operates in three segments: Wholesale, Retail, and Investments and Real Estate. The stock currently has a dividend yield of 1.01%. The company has a P/E ratio of 23.4. Currently, there are no analysts who rate Bassett Furniture Industries a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSET - FREE

TheStreet Quant Ratings rates Bassett Furniture Industries as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Bassett Furniture Industries Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HRG Group (HRG) - FREE Research Report

Harbinger Capital Partners Master Fund I, Ltd., who is 10% Owner at HRG Group, sold 495,000 shares at $12.50 on April 16, 2015. Following this transaction, the 10% Owner owned 3.5 million shares meaning that the stake was reduced by 12.42% with the 495,000-share transaction.

The shares most recently traded at $12.16, down $0.34, or 2.81% since the insider transaction. Historical insider transactions for HRG Group go as follows:

  • 4-Week # shares bought: 5.0 million
  • 4-Week # shares sold: 34,569
  • 12-Week # shares bought: 5.0 million
  • 12-Week # shares sold: 250,000
  • 24-Week # shares bought: 5.0 million
  • 24-Week # shares sold: 5.3 million

The average volume for HRG Group has been 594,600 shares per day over the past 30 days. HRG Group has a market cap of $2.5 billion and is part of the conglomerates sector and conglomerates industry. Shares are down 12.15% year-to-date as of the close of trading on Thursday.

HRG Group, Inc., through its subsidiaries, provides various branded consumer products. The company operates in four segments: Consumer Products, Insurance, Energy, and Financial Services. Currently, there are no analysts who rate HRG Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HRG - FREE

TheStreet Quant Ratings rates HRG Group as a hold. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and weak operating cash flow. Get the full HRG Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null